Literature DB >> 12933836

Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts.

Mark E Lasbury1, Xing Tang, Pamela J Durant, Chao-Hung Lee.   

Abstract

Alveolar macrophages from Pneumocystis carinii-infected hosts are defective in phagocytosis (W. Chen, J. W. Mills, and A. G. Harmsen, Int. J. Exp. Pathol. 73:709-720, 1992; H. Koziel et al., J. Clin. Investig. 102:1332-1344, 1998). Experiments were performed to determine whether this defect is specific for P. carinii organisms. The results showed that these macrophages were unable to phagocytose both P. carinii organisms and fluorescein isothiocyanate (FITC)-conjugated latex beads, indicating that alveolar macrophages from P. carinii-infected hosts have a general defect in phagocytosis. To determine whether this defect correlates with the recently discovered down-regulation of the GATA-2 transcription factor gene during P. carinii infection, alveolar macrophages from dexamethasone-suppressed or healthy rats were treated with anti-GATA-2 oligonucleotides and then assayed for phagocytosis. Aliquots of the alveolar macrophages were also treated with the sense oligonucleotides as the control. Cells treated with the antisense oligonucleotides were found to have a 46% reduction in phagocytosis of P. carinii organisms and a 65% reduction in phagocytosis of FITC-latex beads compared to those treated with the sense oligonucleotides. To determine whether the defect in phagocytosis in alveolar macrophages from P. carinii-infected hosts can be corrected by overexpression of GATA-2, a plasmid containing the rat GATA-2 gene in the sense orientation driven by the cytomegalovirus (CMV) promoter was introduced into alveolar macrophages from P. carinii-infected rats. Aliquots of the same cells transfected with a plasmid containing GATA-2 in the antisense orientation relative to the CMV promoter served as the control. Alveolar macrophages treated with the sense GATA-2 expression construct were found to increase their phagocytic activity by 66% in phagocytosis of P. carinii organisms and by 280% in phagocytosis of FITC-latex beads compared to those that received the antisense GATA-2 construct. The results of this study indicate that GATA-2 plays an important role in the regulation of phagocytosis in alveolar macrophages during P. carinii infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933836      PMCID: PMC187340          DOI: 10.1128/IAI.71.9.4943-4952.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  A soluble mannose receptor immunoadhesin enhances phagocytosis of Pneumocystis carinii by human polymorphonuclear leukocytes in vitro.

Authors:  S E Stehle; R A Rogers; A G Harmsen; R A Ezekowitz
Journal:  Scand J Immunol       Date:  2000-08       Impact factor: 3.487

2.  Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery.

Authors:  Mark E Lasbury; Pamela J Durant; Marilyn S Bartlett; James W Smith; Chao-Hung Lee
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

3.  Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop.

Authors:  J F Murray; C P Felton; S M Garay; M S Gottlieb; P C Hopewell; D E Stover; A S Teirstein
Journal:  N Engl J Med       Date:  1984-06-21       Impact factor: 91.245

4.  Down-regulation of GATA-2 transcription during Pneumocystis carinii infection.

Authors:  X Tang; M E Lasbury; D D Davidson; M S Bartlett; J W Smith; C H Lee
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

5.  Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice.

Authors:  R Paine; A M Preston; S Wilcoxen; H Jin; B B Siu; S B Morris; J A Reed; G Ross; J A Whitsett; J M Beck
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

6.  Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection.

Authors:  B A Garvy; R A Ezekowitz; A G Harmsen
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

7.  N(G)-monomethyl-L-arginine inhibits erythropoietin gene expression by stimulating GATA-2.

Authors:  T Tarumoto; S Imagawa; K Ohmine; T Nagai; M Higuchi; N Imai; N Suzuki; M Yamamoto; K Ozawa
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

8.  GATA2 is required for the generation of V2 interneurons.

Authors:  Y Zhou; M Yamamoto; J D Engel
Journal:  Development       Date:  2000-09       Impact factor: 6.868

Review 9.  A new name (Pneumocystis jiroveci) for Pneumocystis from humans.

Authors:  James R Stringer; Charles B Beard; Robert F Miller; Ann E Wakefield
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

10.  The interaction in vitro of Pneumocystis carinii with macrophages and L-cells.

Authors:  H Masur; T C Jones
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  22 in total

1.  Pneumocystis workshop: 10th anniversary summary.

Authors:  James M Beck; Melanie T Cushion
Journal:  Eukaryot Cell       Date:  2009-01-23

2.  Downregulation of PU.1 leads to decreased expression of Dectin-1 in alveolar macrophages during Pneumocystis pneumonia.

Authors:  Chen Zhang; Shao-Hung Wang; Chung-Ping Liao; Shoujin Shao; Mark E Lasbury; Pamela J Durant; Chao-Hung Lee
Journal:  Infect Immun       Date:  2010-01-11       Impact factor: 3.441

3.  Dendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome.

Authors:  Venetia Bigley; Matthew Collin
Journal:  Haematologica       Date:  2011-08       Impact factor: 9.941

4.  Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia.

Authors:  Guang-Sheng Lei; Chen Zhang; Chao-Hung Lee
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

5.  Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.

Authors:  Amy P Hsu; Elizabeth P Sampaio; Javed Khan; Katherine R Calvo; Jacob E Lemieux; Smita Y Patel; David M Frucht; Donald C Vinh; Roger D Auth; Alexandra F Freeman; Kenneth N Olivier; Gulbu Uzel; Christa S Zerbe; Christine Spalding; Stefania Pittaluga; Mark Raffeld; Douglas B Kuhns; Li Ding; Michelle L Paulson; Beatriz E Marciano; Juan C Gea-Banacloche; Jordan S Orange; Jennifer Cuellar-Rodriguez; Dennis D Hickstein; Steven M Holland
Journal:  Blood       Date:  2011-06-13       Impact factor: 22.113

6.  Mediastinal and Disseminated Mycobacterium kansasii Disease in GATA2 Deficiency.

Authors:  Jana P Lovell; Christa S Zerbe; Kenneth N Olivier; Reginald J Claypool; Cathleen Frein; Victoria L Anderson; Alexandra F Freeman; Steven M Holland
Journal:  Ann Am Thorac Soc       Date:  2016-12

7.  Inhibition of Macrophage Complement Receptor CRIg by TRIM72 Polarizes Innate Immunity of the Lung.

Authors:  Nagaraja Nagre; Xiaofei Cong; César Terrazas; Ian Pepper; John M Schreiber; Hongyun Fu; Joshua M Sill; John W Christman; Abhay R Satoskar; Xiaoli Zhao
Journal:  Am J Respir Cell Mol Biol       Date:  2018-06       Impact factor: 6.914

8.  Defective nitric oxide production by alveolar macrophages during Pneumocystis pneumonia.

Authors:  Mark E Lasbury; Chung-Ping Liao; Chadi A Hage; Pamela J Durant; Dennis Tschang; Shao-Hung Wang; Chen Zhang; Chao-Hung Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-17       Impact factor: 6.914

9.  Microarray studies on effects of Pneumocystis carinii infection on global gene expression in alveolar macrophages.

Authors:  Bi-Hua Cheng; Yunlong Liu; Xiaoling Xuei; Chung-Ping Liao; Debao Lu; Mark E Lasbury; Pamela J Durant; Chao-Hung Lee
Journal:  BMC Microbiol       Date:  2010-04-08       Impact factor: 3.605

10.  GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.

Authors:  Michael A Spinner; Lauren A Sanchez; Amy P Hsu; Pamela A Shaw; Christa S Zerbe; Katherine R Calvo; Diane C Arthur; Wenjuan Gu; Christine M Gould; Carmen C Brewer; Edward W Cowen; Alexandra F Freeman; Kenneth N Olivier; Gulbu Uzel; Adrian M Zelazny; Janine R Daub; Christine D Spalding; Reginald J Claypool; Neelam K Giri; Blanche P Alter; Emily M Mace; Jordan S Orange; Jennifer Cuellar-Rodriguez; Dennis D Hickstein; Steven M Holland
Journal:  Blood       Date:  2013-11-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.